Practice MCQs
COVID-19 surge in India driven by Omicron sub-variants, but no major mutation reported.
As of May 31, India reported 3,395 active COVID-19 cases (increase of 685 since January).
Soumya Swaminathan, former WHO Chief Scientist, stated acquired immunity from infection and vaccination is providing strong protection.
Symptoms are now generally mild, including short-term fever, cough, and body ache.
High-risk individuals (elderly, diabetic, cardiac/lung patients) must remain vigilant.
Advised precautionary measures: masking during illness, hand hygiene, avoiding public spitting.
Detailed Insights:
The current COVID-19 wave is part of an endemic pattern, with low hospitalization and mortality due to widespread immunity.
India and Southeast Asia are witnessing minor, manageable surges, mostly among unboosted or vulnerable populations.
Public health focus has shifted to risk-based guidance rather than blanket restrictions.
Continued communication on hygiene, masking when symptomatic, and booster awareness is critical for long-term containment.
Scientific/Technical Concepts Involved:
Acquired Immunity: Immunity developed through prior infection or vaccination.
Omicron Sub-variants: Genetically mutated versions of the original Omicron strain, known for high transmissibility but lower severity.
Endemic Stage: A phase where disease is regularly found in a population but is manageable and does not cause widespread disruption.
Mains Mock Question:
Examine the key public health measures implemented by India to manage the COVID-19 pandemic, and analyze how acquired immunity contributed to the country’s overall pandemic response.